Valuation: Myomo, Inc.

Market Cap 61.79M 54.34M 51.39M 46.61M 87.53M 5.93B 88.04M 615M 238M 3.03B 232M 227M 9.73B P/E 2026 *
-4.97x
P/E 2027 * -6.55x
Enterprise Value 61.79M 54.34M 51.39M 46.61M 87.53M 5.93B 88.04M 615M 238M 3.03B 232M 227M 9.73B EV / Sales 2026 *
1.35x
EV / Sales 2027 * 1.21x
Free-Float
89.32%
Yield 2026 *
-
Yield 2027 * -
1 day-3.11%
1 week-0.64%
Current month+4.70%
1 month-2.50%
3 months+51.46%
6 months+123.88%
Current year+71.43%
1 week 1.56
Extreme 1.56
1.7
1 month 1.21
Extreme 1.21
1.71
Current year 0.6
Extreme 0.605
1.88
1 year 0.6
Extreme 0.605
1.88
3 years 0.6
Extreme 0.605
7.17
5 years 0.37
Extreme 0.369
14.35
10 years 0.37
Extreme 0.369
695.89
Manager TitleAgeSince
Chief Executive Officer 72 01/07/2011
Director of Finance/CFO 64 18/02/2019
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 72 01/08/2016
Director/Board Member 79 01/03/2012
Director/Board Member 80 01/09/2014
Date Insider Type Main position Quantity % Market Cap. Importance
9/11/26 A Sell

Chief Technology Officer

-15,488 0.0391%
9/2/26 A Sell

Director

-15,000 0.0379%
8/20/26 A Sell

Chief Technology Officer

-17,250 0.0446%
Change 5-day change 1-year change 3-year change Capi.($)
-3.11%-0.64%+67.54%+38.05% 63.77M
-0.31%-1.94%-24.39%+2.91% 175B
+0.97%-2.45%-5.01%+13.74% 113B
-1.01%-4.01%-1.04%+66.14% 58.57B
+0.01%+1.73%-0.42%-30.03% 50.07B
-0.00%+1.19%+15.17%+52.79% 49.92B
+0.07%-2.79%+29.18%-9.20% 32.69B
+1.07%+9.73% - - 30.44B
+1.41%+3.83%+43.64%-0.90% 26.07B
+1.98%+7.44%+26.26%-1.90% 23.55B
Average +0.09%+2.26%+16.77%+14.62% 56B
Weighted average by Cap. +0.19%-0.24%-2.74%+12.67%

Financials

2026 *2027 *
Net sales 45.6M 40.11M 37.93M 34.4M 64.61M 4.38B 64.98M 454M 175M 2.23B 171M 168M 7.18B 51.21M 45.04M 42.59M 38.63M 72.55M 4.92B 72.97M 510M 197M 2.51B 192M 188M 8.06B
Net income -13.37M -11.76M -11.12M -10.08M -18.94M -1.28B -19.05M -133M -51.41M -655M -50.19M -49.1M -2.1B -10.52M -9.25M -8.75M -7.94M -14.91M -1.01B -14.99M -105M -40.46M -515M -39.5M -38.65M -1.66B
Net Debt - -
Logo Myomo, Inc.
Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. The Company develops and markets the MyoPro product line, which is a myoelectric-controlled upper limb brace, or orthosis. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. MyoPro’s control technology utilizes an advanced human-machine interface based on non-invasive, patented electromyography, or EMG, control technology.
Employees
195
Date Price Change Volume
28/09/26 $1.560 -3.11% 278,586
25/09/26 $1.610 -3.59% 221,034
24/09/26 $1.670 +1.83% 273,177
23/09/26 $1.640 0.00% 296,156
22/09/26 $1.640 +4.46% 603,659
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1.560USD
Average target price
4.640USD
Spread / Average Target
+197.44%

Quarterly revenue - Rate of surprise